- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetic Regulation in Melanoma: Facts and Hopes
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 8, Pages 2048
Publisher
MDPI AG
Online
2021-08-11
DOI
10.3390/cells10082048
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic modulation reveals differentiation state specificity of oncogene addiction
- (2021) Mehwish Khaliq et al. Nature Communications
- BRAF Gene and Melanoma: Back to the Future
- (2021) Margaret Ottaviano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epigenetic reprogramming of tumor cell–intrinsic STING function sculpts antigenicity and T cell recognition of melanoma
- (2021) Rana Falahat et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Melanoma subpopulations that rapidly escape MAPK pathway inhibition incur DNA damage and rely on stress signalling
- (2021) Chen Yang et al. Nature Communications
- Role of Epigenetic Regulation in Plasticity of Tumor Immune Microenvironment
- (2021) Yunkai Yang et al. Frontiers in Immunology
- Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy
- (2021) John M. Rieth et al. Cancers
- Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma
- (2020) Shamik Mitra et al. Molecular Oncology
- Gain-of-function genetic alterations of G9a drive oncogenesis
- (2020) Shinichiro Kato et al. Cancer Discovery
- Towards a more precise therapy in cancer: Exploring epigenetic complexity
- (2020) Fernando P. Cossío et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Cutaneous melanoma and the immunotherapy revolution (Review)
- (2020) Giulia Leonardi et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma
- (2020) Friederike Hoffmann et al. Clinical Epigenetics
- Geometric regulation of histone state directs melanoma reprogramming
- (2020) Junmin Lee et al. Communications Biology
- Evolving impact of long-term survival results on metastatic melanoma treatment
- (2020) Olivier Michielin et al. Journal for ImmunoTherapy of Cancer
- Role of miRNAs in Melanoma Metastasis
- (2019) Anna Gajos-Michniewicz et al. Cancers
- MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in BRAF-, NRAS-, and NF1-Mutant Melanomas
- (2019) Ophélia Maertens et al. Cancer Discovery
- Recent success and limitations of immune checkpoint inhibitors for cancer: a lesson from melanoma
- (2019) Margaret Ottaviano et al. VIRCHOWS ARCHIV
- An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells
- (2019) Valentina Perotti et al. ONCOGENE
- Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy
- (2019) Abdullah Al Emran et al. TRENDS IN IMMUNOLOGY
- Epigenetic Mechanisms of Escape from BRAF Oncogene Dependency
- (2019) Khaliq et al. Cancers
- 1370PPhase Ib/II study (SENSITIZE) assessing safety, pharmacokinetics (PK), pharmacodynamics (PD), and clinical outcome of domatinostat in combination with pembrolizumab in patients with advanced melanoma refractory/non-responding to prior checkpoint inhibitor therapy
- (2019) J C Hassel et al. ANNALS OF ONCOLOGY
- Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma
- (2018) Yong Yu et al. CANCER CELL
- LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
- (2018) Wanqiang Sheng et al. CELL
- An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential
- (2018) Liqin Wang et al. CELL
- Long non-coding RNAs in melanoma
- (2018) Xin Yu et al. CELL PROLIFERATION
- Co‐targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor‐resistant melanoma
- (2018) Ileabett M Echevarría‐Vargas et al. EMBO Molecular Medicine
- Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study
- (2018) Sara Valpione et al. EUROPEAN JOURNAL OF CANCER
- A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
- (2018) Deng Pan et al. SCIENCE
- Abstract 4722: 4SC-202 increases immunogenicity of tumor cells, induces infiltration of tumor microenvironment with cytotoxic T cells, and primes tumors for combinations with different cancer immunotherapy approaches
- (2018) Svetlana Hamm et al. CANCER RESEARCH
- Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4
- (2018) Francesca Zanconato et al. NATURE MEDICINE
- SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling
- (2018) Thomas Strub et al. Nature Communications
- Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes
- (2018) Nazar Mashtalir et al. CELL
- PD-L1 methylation regulates PD-L1 expression and is associated with melanoma survival
- (2018) Goran Micevic et al. Pigment Cell & Melanoma Research
- Epigenetic profiling for the molecular classification of metastatic brain tumors
- (2018) Javier I. J. Orozco et al. Nature Communications
- Exploring the epigenetic drug discovery landscape
- (2017) Veda Prachayasittikul et al. Expert Opinion on Drug Discovery
- SWI/SNF complex in cancer
- (2017) Chao Lu et al. NATURE GENETICS
- NRAS-mutant melanoma: current challenges and future prospect
- (2017) Eva Muñoz-Couselo et al. OncoTargets and Therapy
- Distinct histone modifications denote early stress-induced drug tolerance in cancer
- (2017) Abdullah Al Emran et al. Oncotarget
- Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study
- (2017) Yousef Zakharia et al. Oncotarget
- The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
- (2017) Daniel Zingg et al. Cell Reports
- Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
- (2017) Goran Micevic et al. Clinical Epigenetics
- Tissue Stiffness and Hypoxia Modulate the Integrin-Linked Kinase ILK to Control Breast Cancer Stem-like Cells
- (2016) Mei-Fong Pang et al. CANCER RESEARCH
- The future of melanoma therapy: developing new drugs and improving the use of old ones
- (2016) Giuliano Palumbo et al. Future Oncology
- Role of TET enzymes in DNA methylation, development, and cancer
- (2016) Kasper Dindler Rasmussen et al. GENES & DEVELOPMENT
- Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
- (2016) Andrew P. Feinberg et al. NATURE REVIEWS GENETICS
- In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype
- (2016) D. Bossi et al. Cancer Discovery
- Regulation of T Cell Differentiation and Function by EZH2
- (2016) Theodoros Karantanos et al. Frontiers in Immunology
- Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance
- (2015) Willy Hugo et al. CELL
- Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma
- (2015) Chiara Vardabasso et al. MOLECULAR CELL
- The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors
- (2015) Daniel Zingg et al. Nature Communications
- Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem Cells
- (2015) Dana Koludrovic et al. PLoS Genetics
- Antitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse models
- (2015) A Covre et al. OncoImmunology
- Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)
- (2014) Chang Xia et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Decreased Expression of the Chromatin Remodeler ATRX Associates with Melanoma Progression
- (2014) Zulekha A. Qadeer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Epigenetic Regulator I-BET151 Induces BIM-Dependent Apoptosis and Cell Cycle Arrest of Human Melanoma Cells
- (2014) Stuart J. Gallagher et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations
- (2014) D. M. Marzese et al. NEURO-ONCOLOGY
- A stress-induced early innate response causes multidrug tolerance in melanoma
- (2014) D Ravindran Menon et al. ONCOGENE
- Intravital imaging of SRF and Notch signalling identifies a key role for EZH2 in invasive melanoma cells
- (2014) C S Manning et al. ONCOGENE
- Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151
- (2014) Stuart J. Gallagher et al. Pigment Cell & Melanoma Research
- Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
- (2013) Alexander Roesch et al. CANCER CELL
- The CpG Island Methylator Phenotype: What's in a Name?
- (2013) L. A. E. Hughes et al. CANCER RESEARCH
- BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic Therapy
- (2013) M. F. Segura et al. CANCER RESEARCH
- Histone variants: emerging players in cancer biology
- (2013) Chiara Vardabasso et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Epigenetics Meets Radiation Biology as a New Approach in Cancer Treatment
- (2013) Joong-Gook Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity
- (2013) David M. Woods et al. MELANOMA RESEARCH
- Genome-wide promoter methylation analysis identifies epigenetic silencing ofMAPK13in primary cutaneous melanoma
- (2013) Linda Gao et al. Pigment Cell & Melanoma Research
- PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma
- (2013) Yan Ye et al. Nature Communications
- Long Noncoding RNA HOTAIR Is Associated with Motility, Invasion, and Metastatic Potential of Metastatic Melanoma
- (2013) Lihua Tang et al. Biomed Research International
- miR-200c Inhibits Melanoma Progression and Drug Resistance through Down-Regulation of Bmi-1
- (2012) Shujing Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis
- (2012) H. A. Tawbi et al. ANNALS OF ONCOLOGY
- Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
- (2012) Christine Guo Lian et al. CELL
- Convergent Multi-miRNA Targeting of ApoE Drives LRP1/LRP8-Dependent Melanoma Metastasis and Angiogenesis
- (2012) Nora Pencheva et al. CELL
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells
- (2012) Imke Satzger et al. EXPERIMENTAL DERMATOLOGY
- Radiation-Induced Reprogramming of Breast Cancer Cells
- (2012) Chann Lagadec et al. STEM CELLS
- CpG islands and the regulation of transcription
- (2011) A. M. Deaton et al. GENES & DEVELOPMENT
- The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset
- (2011) Craig J. Ceol et al. NATURE
- A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth
- (2011) K L Streicher et al. ONCOGENE
- DNA-methylation profiling distinguishes malignant melanomas from benign nevi
- (2011) Kathleen Conway et al. Pigment Cell & Melanoma Research
- MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma
- (2011) L. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long noncoding RNAs and human disease
- (2011) Orly Wapinski et al. TRENDS IN CELL BIOLOGY
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- Acidic stress promotes a glioma stem cell phenotype
- (2010) A B Hjelmeland et al. CELL DEATH AND DIFFERENTIATION
- High Frequency of p16INK4A Promoter Methylation in NRAS-Mutated Cutaneous Melanoma
- (2010) Anders Jonsson et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The histone variant macroH2A suppresses melanoma progression through regulation of CDK8
- (2010) Avnish Kapoor et al. NATURE
- Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824
- (2009) D. D. Vo et al. CANCER RESEARCH
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Potentiation of a Topoisomerase I Inhibitor, Karenitecin, by the Histone Deacetylase Inhibitor Valproic Acid in Melanoma: Translational and Phase I/II Clinical Trial
- (2009) A. I. Daud et al. CLINICAL CANCER RESEARCH
- CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma
- (2009) A. Tanemura et al. CLINICAL CANCER RESEARCH
- Genome-wide screen of promoter methylation identifies novel markers in melanoma
- (2009) Y. Koga et al. GENOME RESEARCH
- Methylation of PTEN as a Prognostic Factor in Malignant Melanoma of the Skin
- (2009) Christoph Lahtz et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- CpG island methylation profiling in human melanoma cell lines
- (2009) Carmen S. Tellez et al. MELANOMA RESEARCH
- DNA hypomethylation in cancer cells
- (2009) Melanie Ehrlich Epigenomics
- Frequent p16-Independent Inactivation of p14ARF in Human Melanoma
- (2008) Daniel E. Freedberg et al. JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started